Drug name - Baxdela

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9539250 MELINTA Salt and crystalline forms thereof of a drug
Oct, 2025

(3 years from now)

US8273892 MELINTA Salt and crystalline forms thereof of a drug
Aug, 2026

(3 years from now)

US7728143 MELINTA Salt and crystalline forms thereof of a drug
Nov, 2027

(5 years from now)

US8871938 MELINTA Process for making quinolone compounds
Sep, 2029

(6 years from now)

USRE46617 MELINTA Process for making quinolone compounds
Dec, 2029

(7 years from now)

CN102164912A MELINTA Process For Preparing Quinolone Compounds
Sep, 2029

(6 years from now)

CN102164912B MELINTA Preparing Process Of Quinolones Compound
Sep, 2029

(6 years from now)

IN201101315P2 MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

IN290385B MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

EP3056492A1 MELINTA Meglumine Salt And Crystalline Forms Thereof Of A Drug (Delafloxacin)
Oct, 2025

(3 years from now)

EP3056492B1 MELINTA Meglumine Salt And Crystalline Forms Thereof Of A Drug (Delafloxacin)
Oct, 2025

(3 years from now)

EP2346855A4 MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

EP2346855B1 MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

EP2346855A2 MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

EP3214083B1 MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

EP3214083A1 MELINTA Process For Making Quinolone Compounds
Sep, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8969569 MELINTA Salt and crystalline forms thereof of a drug Oct, 2025

(3 years from now)

US8648093 MELINTA Salt and crystalline forms thereof of a drug Oct, 2025

(3 years from now)

US8252813 MELINTA Salt and crystalline forms thereof of a drug Oct, 2026

(3 years from now)

US9750822 MELINTA Sulfoalkyl ether cyclodextrin compositions Mar, 2029

(6 years from now)

US8410077 MELINTA Sulfoalkyl ether cyclodextrin compositions Mar, 2029

(6 years from now)

US9200088 MELINTA Sulfoalkyl ether cyclodextrin compositions Mar, 2029

(6 years from now)

US7635773 MELINTA Sulfoalkyl ether cyclodextrin compositions Mar, 2029

(6 years from now)

US9493582 MELINTA Alkylated cyclodextrin compositions and processes for preparing and using the same Feb, 2033

(10 years from now)

Drugs and Companies using DELAFLOXACIN MEGLUMINE ingredient

Treatment: Treatment of acute bacterial skin and skin structure infections caused by designated susceptible bacteria in adults

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 450MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.